Fed. Circ. Won't Review Ruling Nixing Cordis Stent Patents

Law360, New York (October 11, 2013, 7:49 PM EDT) -- The full Federal Circuit on Friday declined to review a ruling that two Cordis Corp. and Wyeth Pharmaceuticals Inc. patents covering a drug used in stents are invalid, turning aside the companies' claim that the ruling "will cast doubt upon the validity of large numbers of existing patents."

In a June decision, a panel of the Federal Circuit held that the patents are invalid for lack of enablement because one skilled in the art could not practice the full scope of the patents without undue experimentation....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.